JDD June 2025 Issue Highlights | Special Focus: Acne & Rosacea
The June 2025 issue of the Journal of Drugs in Dermatology delivers a diverse and thought-provoking selection of studies that place a spotlight on acne and rosacea while spanning the latest innovations and clinical insights across the dermatology spectrum. This month’s editor’s picks feature new approaches to some of the field’s most common—and challenging—conditions, from acne-induced …
The June 2025 issue of the Journal of Drugs in Dermatology delivers a diverse and thought-provoking selection of studies that place a spotlight on acne and rosacea while spanning the latest innovations and clinical insights across the dermatology spectrum. This month’s editor’s picks feature new approaches to some of the field’s most common—and challenging—conditions, from acne-induced … Continue reading "JDD June 2025 Issue Highlights | Special Focus: Acne & Rosacea"
If you have ever wondered how an ingredient progresses from the laboratory bench to the beauty aisle, or why some products make bold efficacy claims while others remain vague, the field of regulatory affairs is the answer. Acting as the bridge between product innovation and the FDA, regulatory professionals ensure that skin care products of all kinds are compliant with U.S. law. In this session at … 
The management of acne vulgaris has long included a balance between prescription and over-the-counter (OTC) therapies. OTC therapies are typically first-line treatment for most patients, and may be all that is needed to control less severe acne. At the recent Lab to Label Conference, Dr. Hilary Baldwin, a board-certified dermatologist and medical director of the Acne Treatment & Research Cente … 
At the 2025 ODAC Dermatology Conference, we were delighted to learn about alternative treatments for androgenetic alopecia (AGA), presented by Dr. Terrence Keaney, Founder and Director of SkinDC and Clinical Associate Professor of Dermatology at The George Washington University School of Medicine and Health Sciences.
In recent times, there has been an exponential growth of interest from the pat … 
The association between vitiligo and melanoma is complex. While the incidence of vitiligo in patients with melanoma is higher, the risk for the reverse, ie, the development of melanoma in a patient with vitiligo, is thought to be decreased. This report presents a case of melanoma developing on a non-sun-exposed site in a patient with skin of color and untreated vitiligo. It emphasizes the need … 